These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1646420)

  • 1. Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Pertwee RG; Ross TM
    Neuropharmacology; 1991 Jan; 30(1):67-71. PubMed ID: 1646420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental catalepsy: influences of cholinergic transmission in restraint-induced catalepsy.
    Klemm WR
    Experientia; 1983 Feb; 39(2):228-30. PubMed ID: 6682048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Pertwee RG; Greentree SG; Swift PA
    Neuropharmacology; 1988 Dec; 27(12):1265-70. PubMed ID: 2854226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Katsumata Y; Kameyama T; Yamamoto I; Nabeshima T
    J Neural Transm Gen Sect; 1994; 95(2):137-43. PubMed ID: 7865168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice.
    Baratti CM; Huygens P; Miño J; Merlo A; Gardella J
    Psychopharmacology (Berl); 1979 Jun; 64(1):85-8. PubMed ID: 113837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.
    Pertwee RG; Greentree SG
    Neuropharmacology; 1988 May; 27(5):485-91. PubMed ID: 2839791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids.
    Pertwee RG; Wickens AP
    Neuropharmacology; 1991 Mar; 30(3):237-44. PubMed ID: 1649415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1992 May; 57(3):248-55. PubMed ID: 1319706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
    Ahtee L
    Eur J Pharmacol; 1976 Oct; 39(2):203-13. PubMed ID: 987911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the cataleptic activity of various derivates of butyrophenone].
    Timsit J
    Therapie; 1966; 21(6):1453-71. PubMed ID: 6012227
    [No Abstract]   [Full Text] [Related]  

  • 18. Responses of thalamic neurones to iontophoretically applied drugs.
    McCance I; Phillis JW; Westerman RA
    Nature; 1966 Feb; 209(5024):715-6. PubMed ID: 5922134
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual transmission in the stellate ganglion of the dog.
    Flacke W; Gillis RA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):165-6. PubMed ID: 4385650
    [No Abstract]   [Full Text] [Related]  

  • 20. Berry CA: Effect of cholinergic drugs on passive avoidance in the mouse.
    Dilts SL
    J Pharmacol Exp Ther; 1967 Nov; 158(2):279-85. PubMed ID: 6065151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.